ASRA + SOAP Comment on ASRA App, Guidelines on Subcutaneous
On behalf of the American Society of Regional Anesthesia and Pain Medicine (ASRA) and the Society for Obstetric Anesthesia and Perinatology (SOAP), we would like to follow up on the article “Obstetric Guidelines Affect Heparin and Neuraxial Anesthesia Practice—ASRA app prompts some confusion,” which appeared in your October 2016 issue, to provide some context. The major points of the article are that the new ASRA guidelines regarding subcutaneous standard heparin will have a significant impact on the management of selected antepartum patients for whom it is now recommended that thromboprophylaxis be administered1 (and that the ASRA recommendations were not adequately vetted), as well as the delay in the publication of these guidelines.

http://www.anesthesiologynews.com/Correspondence/Article/01-17/ASRA-SOAP-Comment-on-ASRA-App-Guidelines-on-Subcutaneous-Heparin/38971
Dr. N●●●●m S●●●h and 1 others like this
Like
Comment
Share